SCHEMBL24715876

SCHEMBL24715876

Oc1ccc(Cl)c2c(C3CCCCC3)ccnc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.41
HSP90AA1 P07900 2/20 0.41
BRD4 O60885 2/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
NUDT1 P36639 1/20 0.35
BACE1 P56817 1/20 0.35
COMT P21964 2/20 0.35
FLT3 P36888 2/20 0.34
THRB P10828 1/20 0.34
CHEK1 O14757 1/20 0.34
NTRK1 P04629 1/20 0.34
FYN P06241 1/20 0.34
RET P07949 1/20 0.34
MET P08581 1/20 0.34
PDGFRB P09619 1/20 0.34
PIM1 P11309 1/20 0.34
FGFR1 P11362 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24715777 0.92 KDM4E (0.44) KDM4EHSP90AA1BRD4LMNAMAPT
SCHEMBL25250849 0.77 HSP90AA1 (0.49) KDM4EHSP90AA1BRD4LMNAMAPT
SCHEMBL25291011 0.75 MAPT (0.48) KDM4EHSP90AA1BRD4LMNAMAPT
SCHEMBL24715874 0.75 KDM4E (0.55) KDM4EHSP90AA1BRD4LMNAMAPT
SCHEMBL27190084 0.73 KDM4E (0.57) KDM4EHSP90AA1LMNAMAPTCOMT
SCHEMBL24715901 0.73 KDM4E (0.49) KDM4EHSP90AA1BRD4LMNAMAPT
SCHEMBL24715779 0.71 PDE4B (0.36) KDM4EMAPTCDK9DYRK1ACYP17A1
SCHEMBL17931872 0.70 COMT (0.55) KDM4EHSP90AA1BRD4LMNAMAPT
SCHEMBL25290064 0.69 MAPT (0.50) KDM4EHSP90AA1BRD4LMNAMAPT
SCHEMBL24322947 0.67 CYP17A1 (0.35) COMTCYP17A1CELGCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4623914-A1 USE OF 8-HYDROXYQUINOLINE DERIVATIVE Jiangsu Yahong Meditech Co., Ltd. (CN) 2025-10-01 EP disclosed
CN-120035438-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2025-05-23 CN disclosed
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF JIANGSU YAHONG MEDITECH CO., LTD. (CN) 2024-07-25 US disclosed
CN-118059101-A Use of 8-hydroxyquinoline derivatives 江苏亚虹医药科技股份有限公司 2024-05-24 CN disclosed
EP-4349815-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF Jiangsu Yahong Meditech Co., Ltd. (CN) 2024-04-10 EP disclosed
CN-117043141-A 7-nitro-8-hydroxyquinoline derivative, preparation method and medical application thereof 江苏亚虹医药科技股份有限公司 2023-11-10 CN disclosed
WO-2022253152-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2022-12-08 WO disclosed
WO-2022253152-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 江苏亚虹医药科技股份有限公司 2022-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240246916-A1 7-NITRO-8-HYDROXYQUINOLINE DERIVATIVES, PREPARATION METHOD THEREFORE AND MEDICAL USE THEREOF CYP3A7, UGT1A7, UGT2B7 KDM4E 2921/4885HSP90AA1 888/4885BRD4 3065/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.